Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
Biotech
Market volatility adds to 'already challenging' year for IPOs
The past week's market turbulence will likely dry up the trickle of biotech IPOs that were expected in 2025, a capital markets expert has told Fierce.
James Waldron
Apr 11, 2025 9:25am
Artificial heart maker Picard Medical plans to go public
Apr 1, 2025 12:30pm
Wearable defibrillator maker Kestra Medical plots $150M IPO
Feb 26, 2025 12:00pm
Aardvark secures $94M IPO to fund appetite-suppressant trials
Feb 13, 2025 8:10am
Sionna goes public in $135M IPO, Aardvark plots $103M listing
Feb 7, 2025 4:40am
Sionna eyes up $156M IPO to fund cystic fibrosis trials
Feb 3, 2025 9:59am